Penelope A. Kosinski

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease”.

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

Blood(2022)10.1182/blood.2022015403

N/A

2.4DataRank · unranked

74 citations

Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A. Menapace, Laxminath Tumburu +15 more

Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation

Blood Advances(2024)10.1182/bloodadvances.2024013504

N/A

0.461DataRank · unranked

15 citations

Xunde Wang, Jonathan M. Chu, Maureen Lundt, Yuan Yee Lee, Anna Conrey +9 more

Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model

Blood Cells Molecules and Diseases(2022)10.1016/j.bcmd.2022.102660

N/A

0DataRank · unranked

37 citations

Sayuri Kamimura, Meghann L. Smith, Xunde Wang, Michael R. Heaven, Sirsendu Jana +17 more